Login / Signup

Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma.

XiaoChang FangLin ShuTianLiang ChenXiaoLe ZhaoLiuCui YangTingting DouLijie YangXuanfei LiMaohui Feng
Published in: Molecular cancer (2024)
This study presents a method for generating human MPM organoids, which can serve as a valuable research tool and contribute to the advancement of MPM research. Additionally, these organoids can be utilized as a means to evaluate the effectiveness of drug treatments for MPM patients, offering a model for personalized treatment approaches.
Keyphrases